Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Anal Biochem ; 656: 114876, 2022 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-36058293

RESUMO

Paired box protein Pax-6 (oculothrombin) is a transcription factor that plays an important regulatory role in ocular, brain, and pancreatic development. Mutations of the PAX6 gene cause aniridia and Peters anomaly. Reduction in Pax-6 protein is also associated with ocular diseases such as dry eye. An electrochemiluminescence immunoassay method using the Meso Scale Discovery platform was developed to measure Pax-6 protein levels in corneal epithelial cells obtained by impression cytology. Impression cytology involves harvesting ocular epithelial cells by applying a polyethersulfone membrane patch briefly to the ocular surface using a commercially available EYEPRIM™ device. The epithelial cells that adhere to the membrane patch of the EYEPRIM™ device provide a biological sample which can be assayed for Pax-6 protein levels. Assay development identified an antibody pair capable of detecting purified recombinant Pax-6 protein produced in mammalian cells. The optimized assay has a dynamic range of 24 pg mL-1 to 100,000 pg mL-1 and a lower limit of quantification of 24 pg mL-1. Assay selectivity was demonstrated using either HeLa or HEK293 cells transfected with inhibitory RNA. Finally, the method was validated by measuring Pax-6 protein levels in impression cytology acquired samples obtained using the EYEPRIM™ device from rabbit cornea.


Assuntos
Proteínas de Homeodomínio , Fatores de Transcrição Box Pareados , Animais , Proteínas do Olho/genética , Células HEK293 , Proteínas de Homeodomínio/genética , Humanos , Imunoensaio , Mamíferos/genética , Mamíferos/metabolismo , Fator de Transcrição PAX6 , Fatores de Transcrição Box Pareados/genética , RNA , Coelhos , Proteínas Repressoras/genética
2.
Exp Eye Res ; 83(2): 390-400, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16631164

RESUMO

To determine whether vitreous lactate concentrations are correlated with intraocular pressure (IOP) rise, retinal ganglion cell (RGC) damage, and nerve fiber layer (NFL) thickness decrease in a rabbit model of ocular hypertension. Also, to learn whether proton nuclear magnetic resonance ((1)H-NMR) spectroscopy can provide sequential, non-invasive in vivo measurements of vitreous lactate. Intra-anterior chamber injections of 20-mum latex beads were used to impede aqueous drainage in New Zealand White rabbits, causing an elevation of IOP. Group I consisted of 12 rabbits in which unilateral elevations in IOP were achieved. Group II consisted of 6 rabbits in which treatment did not cause a change in IOP. The contralateral eye served as a control in both groups. Control eyes received an equal volume injection of vehicle only. IOP was measured for two pre-treatment days and then on post-treatment days 1, 3, 5, 7, 9, 16, 23, 30, and 37. (1)H-NMR spectroscopy was used to measure changes in vitreous lactate concentrations that may be associated with the onset and progression of the pathophysiology. Post-mortem histochemical analysis at the light microscope level was used to quantify changes in the retinal NFL thickness and in the numbers of RGC, and correlate them with IOP and percent change in lactate levels. Baseline IOP in Group I control and treated eyes were 12.0+/-1.9 and 12.5+/-1.3 mmHg, respectively. Between days 5 and 9 post-treatment, the IOP in Group I treated eyes (n=12) rose to 23.9+/-4.2 mmHg. IOP in the control eyes remained unchanged (12.0+/-1.6). Vitreous lactate levels in Group I treated eyes increased by 100%, from pre-treatment values. Levels in control eyes remained unchanged. In Group I, IOP and percent change in lactate concentration in treated eyes were closely correlated throughout the study period (r=0.95; p< or =0.05). Group II control and treated eyes showed no significant changes in either IOP or lactate. Group I treated eyes had a reduced NFL thickness (65+/- 4 microm; n=5) at the temporal medullary ray (MR) compared with control eyes (45+/-6 microm). A smaller reduction was found in the nasal MR areas, where thickness was 53+/-3 microm in treated eyes and 66+/-4 microm in control eyes. RGC numbers also were decreased in the treated eyes (241,222+/-10,920 cells) vs. 322,311+/-8726 cells in control eyes. TdT-mediated dUTP nick-end labeling (TUNEL) indicated that RGC loss in the treated eyes was most likely due to apoptosis. In vivo changes in lactate can be monitored non-invasively over time using (1)H-NMR spectroscopy. Vitreous lactate concentrations increased and returned to baseline concurrently with IOP. The brief elevation in IOP produced a reduction in both the RGC cell numbers and in the thickness of the NFL.


Assuntos
Lactatos/análise , Espectroscopia de Ressonância Magnética/métodos , Hipertensão Ocular/metabolismo , Corpo Vítreo/química , Animais , Apoptose/fisiologia , Contagem de Células , Modelos Animais de Doenças , Marcação In Situ das Extremidades Cortadas/métodos , Pressão Intraocular/fisiologia , Fibras Nervosas/patologia , Hipertensão Ocular/patologia , Prótons , Coelhos , Células Ganglionares da Retina/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA